Moffitt Researchers ID Gene Variations in Lung Cancer Patients That May Help Predict an Individual’s Treatment Response
Four gene variants found in non-small cell lung cancer patients indicate an increased risk of death.
Read More
Search Results for: lung cancer
FDA Approves QIAGEN’s therascreen EGFR Test as Companion Diagnostic for Lung Cancer Patients
The test addresses high-volume, high-value need with broad coverage of validated mutations.
Read More
Roche Gets FDA Approval for First Companion Diagnostic to Detect Gene Mutation Linked with a Type of Lung Cancer
This is the first FDA-approved companion diagnostic that detects epidermal growth factor receptor gene mutations, which are present in approximately 10% of non-small cell lung cancers.
Read More
Biodesix’ VeriStrat Helps Personalize Therapy for Elderly Patients With Lung Cancer
Data published in Journal of Thoracic Oncology.
Read More
FDA Clears ALK Automated Gene Scanner for Lung Cancer Therapy-Selection from ASI
The platform offers clinicians a way to automatically perform genetic analysis on tissue samples, stained with the Abbott ALK probe kit, and identify the ALK gene rearrangement.
Read More